米国の医療機器メーカー市場規模、シェア、動向分析レポート：用途別、セグメント別予測、2024-2030年

米国の医療機器メーカー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の医療機器メーカー市場規模は2030年までに3,601億米ドルに達し、CAGR 5.8％で拡大すると予測されています。

この地域市場は、同国の高いヘルスケア支出によって大きく牽引されています。高齢者人口の増加と慢性疾患の有病率の上昇も、予測期間中の市場成長を増大させると予測されています。

COVID-19パンデミックは、手袋、注射器、マスク、PPEキット、赤外線体温計、パルスオキシメーター、検査キットなどの医療消耗品や患者補助具の需要を激増させる引き金となった。この結果、既存プレーヤーだけでなく新規参入者にも絶大なビジネスチャンスがもたらされました。しかし、パンデミックはまた、肥満手術、関節置換手術、美容整形手術などの選択的手術の大幅な減少をもたらし、前述の手術で使用される医療機器の成長を制限しました。2021年半ば以降は、選択的手術の再開に向けた政府の積極的な取り組みにより、市場の回復が期待できます。

米国では、医療機器の研究開発への投資が増加しており、先端技術の採用率も高いことから、医療機器メーカーにとって絶好のビジネス環境となっています。同国における低侵襲手術の採用増加も市場を牽引しています。さらに、座りっぱなしのライフスタイルが原因で引き起こされる病気と相まって、不慮の事故によるケースの増加が予測期間中の市場成長を促進します。

米国には、米国のメディケア制度など有利な償還政策があります。Boston Scientific Corp.社は、Medicare and Medicaid Services（CMS）と提携し、CコードでカバーされるAPC（Ambulatory Payment Classifications）に該当するすべての機器に対する償還を提供しています。このような有利な償還構造は市場の成長を促進すると予想されるが、日進月歩の規制の性質上、突然の改正が行われる可能性があり、市場に大きな影響を与える可能性があります。

米国の医療機器メーカー市場レポート・ハイライト

• ドラッグデリバリーデバイスは2023年に28.2%という圧倒的な市場シェア。推定シェアの要因としては、患者の利便性とコンプライアンス、慢性疾患の有病率の上昇、疾患管理を改善する技術の進歩、老年人口の増加など
• 2023年3月、米国ノースウェスタン大学の科学者チームが、オピオイドの蔓延やがん治療、リハビリテーション医療の改善に役立つと期待される新規ドラッグデリバリー技術を開発
• 業界リーダーによる戦略的イニシアチブの高まりも市場成長の原動力に
• 2023年、MedtronicとDaVita Inc.社はMozarc Medicalルの設立を発表しました。同社は、腎臓の健康のためのソリューションの創造を目指しています。
• さらに2023年、GEヘルスケアはBiomedical Advanced Research and Development Authorityと4,400万米ドルの契約を締結しました。この契約の中でGEは、外傷性傷害を治療するための診断および画像ソリューションを提供する予定です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の医療機器メーカーの市場変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国の医療機器メーカーの市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の医療機器メーカー市場：用途の推定・動向分析

• 用途市場シェア、2023年と2030年
• セグメントダッシュボード
• 用途別の米国の医療機器メーカー市場の見通し

第5章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
• ベンダー情勢
  • Key company market share analysis, 2023
  • Stryker
  • Cardinal Health
  • Eli Lily and Company
  • Intuitive Surgical
  • Edwards Lifesciences Corporation
  • BD
  • Danaher
  • 3M
  • Abbott
  • Baxter
  • B. Braun SE
  • GE HealthCare
  • Johnson &Johnson Services, Inc.
  • Medtronic
  • Boston Scientific Corporation

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 U.S. Medical Device Manufacturers market revenue estimates and forecast, by application, 2018 - 2030 (USD Billion)
• Table 4 Key companies undergoing acquisitions/expansions
• Table 5 Key companies undergoing product launch/approval
• Table 6 Key companies undergoing partnership & collaboration

List of Figures

• Fig. 1 U.S. Medical Device Manufacturers market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Market snapshot
• Fig. 8 Competitive landscape
• Fig. 9 Market Dynamics
• Fig. 10 U.S. Medical Device Manufacturers market: PORTER's analysis
• Fig. 11 U.S. Medical Device Manufacturers market: PESTEL analysis
• Fig. 12 U.S. Medical Device Manufacturers market: by application: key takeaways
• Fig. 13 U.S. Medical Device Manufacturers market, by application: market share, 2023 & 2030
• Fig. 14 Orthopedic devices market, 2018 - 2030 (USD Billion)
• Fig. 15 Cardiovascular devices market, 2018 - 2030 (USD Billion)
• Fig. 16 Neurology devices market, 2018 - 2030 (USD Billion)
• Fig. 17 Drug delivery devices market, 2018 - 2030 (USD Billion)
• Fig. 18 Ophthalmic devices market, 2018 - 2030 (USD Billion)
• Fig. 19 Nephrology and urology devices market, 2018 - 2030 (USD Billion)
• Fig. 20 Others market, 2018 - 2030 (USD Billion)
• Fig. 21 Key company categorization
• Fig. 22 Heat map analysis
• Fig. 23 U.S orthopedic devices market share analysis, 2023
• Fig. 24 U.S cardiac care devices market share analysis, 2023
• Fig. 25 U.S drug delivery devices market share analysis, 2023
• Fig. 26 Strategic framework 

U.S. Medical Device Manufacturers Market Growth & Trends:

The U.S. medical device manufacturers market size is expected to reach USD 360.1 billion by 2030 and is projected to expand at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. The regional market is significantly driven by the high healthcare expenditure of the country. The increasing geriatric population coupled with the rising prevalence of chronic diseases is also expected to augment the market growth over the forecast period.

The COVID-19 pandemic triggered a drastic rise in demand for medical consumables and patient aids, such as gloves, syringes, masks, PPE kits, infrared thermometers, pulse oximeter, testing kits, etc. This resulted in an immense opportunity for the existing players as well as new entrants. However, the pandemic also resulted in a massive reduction in elective procedures, such as bariatric surgeries, joint replacement surgeries, cosmetic surgeries, etc., thus restricting the growth of medical devices used in the aforementioned procedures. The market recovery can be expected from mid-2021 onwards with favorable government initiatives to re-launch elective procedures.

Growing investments in medical device R&D along with the high adoption rate of advanced technology in the U.S., create the perfect business environment for medical device manufacturers in the country, providing them with lucrative opportunities to accelerate their business operations. Increasing adoption of minimally invasive surgeries in the country is also driving the market. In addition, rising cases of accidental injuries coupled with diseases caused due to sedentary lifestyle will propel the market growth over the forecast period.

The U.S. has favorable reimbursement policies such as the U.S. Medicare system. Boston Scientific Corp., in association with the Centers for Medicare and Medicaid Services (CMS), offers reimbursement for all devices that fall under Ambulatory Payment Classifications (APCs), covered under C-codes. These favorable reimbursement structures are expected to fuel market growth; however, the ever-evolving nature of regulations may lead to abrupt amends, which may significantly impact the market.

U.S. Medical Device Manufacturers Market Report Highlights:

• Drug delivery devices held a dominant market share of 28.2% in 2023. Factors responsible for the estimated share include patient convenience and compliance, rising prevalence of chronic diseases, technological advancements to improve disease management, and increasing geriatric population.
• In March 2023, a team of scientists at Northwestern University, U.S., developed a novel drug-delivery technology that is expected to have implications for the opioid epidemic and cancer treatment and to improve rehabilitation care.
• The growing strategic initiative by industry leaders is also driving market growth
• In 2023, Medtronic and DaVita Inc. announced the launch of a new company, Mozarc Medical. The company aims to create solutions for kidney health.
• Furthermore, in 2023, GE HealthCare signed a USD 44 million contract with the Biomedical Advanced Research and Development Authority. Within this contract, GE is expected to provide diagnostic and imaging solutions to treat traumatic injuries.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in U.S.
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Medical Device Manufacturers Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing geriatric population
    • 3.2.1.2. High adoption of minimally invasive procedures
    • 3.2.1.3. Increase in the number of sports and road accidents
    • 3.2.1.4. Increasing geographic reach of market players
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Increase in the number of product recalls
    • 3.2.2.2. Social and ethical issues
    • 3.2.2.3. Slow approval procedures
• 3.3. U.S. Medical Device Manufacturers Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Medical Device Manufacturers Market: Application Estimates & Trend Analysis

• 4.1. Application Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Medical Device Manufacturers Market by Application Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Orthopedic Devices
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.2. Cardiovascular Devices
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.3. Neurology Devices
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.4. Drug Delivery Devices
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.5. Ophthalmic Devices
    • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.6. Nephrology and Urology Devices
    • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.7. Others
    • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

• 5.1. Recent Developments & Impact Analysis, By Key Market Participants
• 5.2. Company/Competition Categorization
• 5.3. Vendor Landscape
  • 5.3.1. Key company market share analysis, 2023
  • 5.3.2. Stryker
    • 5.3.2.1. Company overview
    • 5.3.2.2. Financial performance
    • 5.3.2.3. Product benchmarking
    • 5.3.2.4. Strategic initiatives
  • 5.3.3. Cardinal Health
    • 5.3.3.1. Company overview
    • 5.3.3.2. Financial performance
    • 5.3.3.3. Product benchmarking
    • 5.3.3.4. Strategic initiatives
  • 5.3.4. Eli Lily and Company
    • 5.3.4.1. Company overview
    • 5.3.4.2. Financial performance
    • 5.3.4.3. Product benchmarking
    • 5.3.4.4. Strategic initiatives
  • 5.3.5. Intuitive Surgical
    • 5.3.5.1. Company overview
    • 5.3.5.2. Financial performance
    • 5.3.5.3. Product benchmarking
    • 5.3.5.4. Strategic initiatives
  • 5.3.6. Edwards Lifesciences Corporation
    • 5.3.6.1. Company overview
    • 5.3.6.2. Financial performance
    • 5.3.6.3. Product benchmarking
    • 5.3.6.4. Strategic initiatives
  • 5.3.7. BD
    • 5.3.7.1. Company overview
    • 5.3.7.2. Financial performance
    • 5.3.7.3. Product benchmarking
    • 5.3.7.4. Strategic initiatives
  • 5.3.8. Danaher
    • 5.3.8.1. Company overview
    • 5.3.8.2. Financial performance
    • 5.3.8.3. Product benchmarking
    • 5.3.8.4. Strategic initiatives
  • 5.3.9. 3M
    • 5.3.9.1. Company overview
    • 5.3.9.2. Financial performance
    • 5.3.9.3. Product benchmarking
    • 5.3.9.4. Strategic initiatives
  • 5.3.10. Abbott
    • 5.3.10.1. Company overview
    • 5.3.10.2. Financial performance
    • 5.3.10.3. Product benchmarking
    • 5.3.10.4. Strategic initiatives
  • 5.3.11. Baxter
    • 5.3.11.1. Company overview
    • 5.3.11.2. Financial performance
    • 5.3.11.3. Product benchmarking
    • 5.3.11.4. Strategic initiatives
  • 5.3.12. B. Braun SE
    • 5.3.12.1. Company overview
    • 5.3.12.2. Financial performance
    • 5.3.12.3. Product benchmarking
    • 5.3.12.4. Strategic initiatives
  • 5.3.13. GE HealthCare
    • 5.3.13.1. Company overview
    • 5.3.13.2. Financial performance
    • 5.3.13.3. Product benchmarking
    • 5.3.13.4. Strategic initiatives
  • 5.3.14. Johnson & Johnson Services, Inc.
    • 5.3.14.1. Company overview
    • 5.3.14.2. Financial performance
    • 5.3.14.3. Product benchmarking
    • 5.3.14.4. Strategic initiatives
  • 5.3.15. Medtronic
    • 5.3.15.1. Company overview
    • 5.3.15.2. Financial performance
    • 5.3.15.3. Product benchmarking
    • 5.3.15.4. Strategic initiatives
  • 5.3.16. Boston Scientific Corporation
    • 5.3.16.1. Company overview
    • 5.3.16.2. Financial performance
    • 5.3.16.3. Product benchmarking
    • 5.3.16.4. Strategic initiatives